News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

EDEN Bioscience (EDEN) Receives Delisting Warning Letter From Nasdaq


9/18/2007 10:57:46 AM

BOTHELL, WA--(MARKET WIRE)--Sep 18, 2007 -- Eden Bioscience Corporation (NasdaqCM:EDEN - News) today announced that on September 12, 2007 it received a Nasdaq Staff Deficiency Letter from the Nasdaq Stock Market notifying it that the bid price per share for the Company's common stock has closed below the $1.00 minimum bid price requirement for 30 consecutive trading days and that, as a result, the Company no longer meets The Nasdaq Capital Market's minimum bid price requirement for continued listing set forth in Marketplace Rule 4310(c)(4).

Read at press release


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES